Home/Filings/4/0000950170-25-053373
4//SEC Filing

Zakrzewski Joseph S 4

Accession 0000950170-25-053373

CIK 0001880438other

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 5:08 PM ET

Size

5.4 KB

Accession

0000950170-25-053373

Insider Transaction Report

Form 4
Period: 2025-04-10
Transactions
  • Award

    Common Stock

    2025-04-10+10,523145,538 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    405,880
Footnotes (2)
  • [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
  • [F2]These shares are held by Z3 Trust, for which the Reporting Person is a trustee.

Documents

1 file

Issuer

AN2 Therapeutics, Inc.

CIK 0001880438

Entity typeother

Related Parties

1
  • filerCIK 0001331852

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 5:08 PM ET
Size
5.4 KB